Janus Kinase Inhibitors Market Poised for Steady Growth as Autoimmune Disease Therapies Advance
The global Janus Kinase JAK Inhibitors Market is on a steady growth trajectory, driven by the increasing prevalence of autoimmune diseases, the growing demand for targeted therapies, and continuous advancements in drug development. According to a comprehensive report by Wise Guy Reports, the market was valued at USD 4.4 billion in 2024. It is projected to grow from USD 4.7 billion in...
0 Commentarios 0 Acciones 65 Views 0 Vista previa
SocioMint https://sociomint.com